Chairman of the Board
James Geraghty was appointed a member of the Board of Directors and Chairman of the Board in July 2013. Currently an Entrepreneur-in-Residence at Third Rock Ventures, Jim served as Senior VP, North America Strategy and Business Development at Sanofi, where he was a member of the Office of the CEO. Prior to Sanofi, Jim spent 20 years at Genzyme Corporation, and helped Genzyme introduce rare disease therapies around the world. His roles included Senior VP, President of Genzyme Europe, where he oversaw several new product launches, and General Manager of Genzyme’s cardiovascular business, where he guided the development of a recently approved antisense product, He also led strategic in-licensing transactions and divestitures. He was previously Chairman, President and CEO of Genzyme Transgenics Corporation (now Revo Biologics), which he founded and took public. Jim also serves as chairman of the board of Juniper Pharmaceuticals, and as a trustee of the Joslin Diabetes Center. He holds a JD from the Yale Law School, an MS from the University of Pennsylvania, and a BA from Georgetown University.